Literature DB >> 21626505

The HOX gene network in hepatocellular carcinoma.

Clemente Cillo1, Giulia Schiavo, Monica Cantile, Michel P Bihl, Paolo Sorrentino, Vincenza Carafa, Maria D' Armiento, Massimo Roncalli, Sebastiano Sansano, Raffaela Vecchione, Luigi Tornillo, Lucia Mori, Gennaro De Libero, Jessica Zucman-Rossi, Luigi Terracciano.   

Abstract

Liver organogenesis and cancerogenesis share common mechanisms. HOX genes control normal development, primary cellular processes and are characterized by a unique genomic network organization. Less is known about the involvement of HOX genes with liver cancerogenesis. The comparison of the HOX gene network expression between nontumorous livers and hepatocellular carcinomas (HCCs) highlights significant differences in the locus A HOX genes, located on chromosome 7, with a consistent overexpression of HOXA13 mRNA thus validating this gene deregulation as a feature of HCC. HOXA13 is a determinant of gut primordia and posterior body structures. Transcriptome analysis of HCC/nontumorous liver mRNAs, selected on the basis of HOXA13 overexpression, recognizes a set of deregulated genes. The matching of these genes with previously reported HCC transcriptome analysis identifies cell-cycle and nuclear pore-related HCC phenotype displaying poor prognosis. HOXA13 and HOXA7 homeoproteins share a consensus sequence that physically links eIF4E nuclear bodies acting on the export of specific mRNAs (c-myc, FGF-2, vascular endothelial growth factor (VEGF), ornithine decarboxylase (ODC) and cyclin D1). We report the protein-protein interaction between HOXA13 and eIF4E in liver cancer cells and the deregulation of eIF4E mRNA and protein in cell cycle/nuclear pore HCC group phenotype and in T4 stage HCCs, respectively. Thus, transcriptional and post-transcriptional HOXA13 deregulation is involved in HCC possibly through the mRNA nuclear export of eIF4E-dependent transcripts.
Copyright © 2011 UICC.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21626505     DOI: 10.1002/ijc.25941

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  30 in total

1.  MicroRNA-147 suppresses human hepatocellular carcinoma proliferation migration and chemosensitivity by inhibiting HOXC6.

Authors:  Cheng-Jun Sui; Feng Xu; Wei-Feng Shen; Bing-Hua Dai; Jiong-Jiong Lu; Min-Feng Zhang; Jia-Mei Yang
Journal:  Am J Cancer Res       Date:  2016-12-01       Impact factor: 6.166

2.  Long noncoding RNA HOTTIP/HOXA13 expression is associated with disease progression and predicts outcome in hepatocellular carcinoma patients.

Authors:  Luca Quagliata; Matthias S Matter; Salvatore Piscuoglio; Leila Arabi; Christian Ruiz; Alfredo Procino; Michal Kovac; Francesca Moretti; Zuzanna Makowska; Tujana Boldanova; Jesper B Andersen; Monika Hämmerle; Luigi Tornillo; Markus H Heim; Sven Diederichs; Clemente Cillo; Luigi M Terracciano
Journal:  Hepatology       Date:  2014-01-28       Impact factor: 17.425

3.  Analysis of expression profile data identifies key genes and pathways in hepatocellular carcinoma.

Authors:  Xuwei Jiang; Yuqing Hao
Journal:  Oncol Lett       Date:  2017-12-06       Impact factor: 2.967

4.  Deregulation of paralogous 13 HOX genes in oral squamous cell carcinoma.

Authors:  Gabriella Aquino; Renato Franco; Rocco Sabatino; Elvira La Mantia; Giosuè Scognamiglio; Francesca Collina; Francesco Longo; Franco Ionna; Nunzia S Losito; Giuseppina Liguori; Gerardo Botti; Monica Cantile
Journal:  Am J Cancer Res       Date:  2015-09-15       Impact factor: 6.166

Review 5.  Multiple roles of HOX proteins in Metastasis: Let me count the ways.

Authors:  Joy Jonkers; Priya Pai; Saraswati Sukumar
Journal:  Cancer Metastasis Rev       Date:  2020-09       Impact factor: 9.264

6.  Dysregulated expression of homebox gene HOXA13 is correlated with the poor prognosis in bladder cancer.

Authors:  Haiyi Hu; Yuebing Chen; Sheng Cheng; Gonghui Li; Zhigen Zhang
Journal:  Wien Klin Wochenschr       Date:  2016-11-09       Impact factor: 1.704

7.  Identification and validation that up-expression of HOXA13 is a novel independent prognostic marker of a worse outcome in gastric cancer based on immunohistochemistry.

Authors:  Yang Han; Wei-Wei Tu; Yu-Gang Wen; Da-Peng Li; Guo-Qiang Qiu; Hua-Mei Tang; Zhi-Hai Peng; Chong-Zhi Zhou
Journal:  Med Oncol       Date:  2013-04-17       Impact factor: 3.064

8.  Upregulation of HOXB7 promotes the tumorigenesis and progression of gastric cancer and correlates with clinical characteristics.

Authors:  Jia-Qin Cai; Xiao-Wu Xu; Yi-Ping Mou; Ke Chen; Yu Pan; Di Wu
Journal:  Tumour Biol       Date:  2015-08-26

9.  Menin promotes hepatocellular carcinogenesis and epigenetically up-regulates Yap1 transcription.

Authors:  Bin Xu; Shan-Hua Li; Rong Zheng; Shu-Bin Gao; Li-Hong Ding; Zhen-Yu Yin; Xiao Lin; Zi-Jie Feng; Sheng Zhang; Xiao-Min Wang; Guang-Hui Jin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-07       Impact factor: 11.205

10.  Hyperexpression of HOXC13, located in the 12q13 chromosomal region, in well‑differentiated and dedifferentiated human liposarcomas.

Authors:  Monica Cantile; Francesca Galletta; Renato Franco; Gabriella Aquino; Giosuè Scognamiglio; Laura Marra; Margherita Cerrone; Gabriella Malzone; Angela Manna; Gaetano Apice; Flavio Fazioli; Gerardo Botti; Annarosaria De Chiara
Journal:  Oncol Rep       Date:  2013-10-01       Impact factor: 3.906

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.